Ciba-Geigy's Voltaren
Executive Summary
Ex-New York Yankees Mickey Mantle and Whitey Ford appeared at Ciba-Geigy exhibit booth at the American Society of Hospital Pharmacists meeting in New Orleans Dec. 9. They were accompanied by Paul Greenberg, MD, a Voltaren clinical investigator, who introduced the two and briefly discussed the clinical trials. Company representatives accepted written requests for autographs. Ciba-Geigy said the appearances do not contradict its recently announced changes to its advertising policies ("The Pink Sheet" Sept. 23, p. 16). While the company has foresworn the use of celebrity endorsements to lay audiences, Ciba-Geigy believes that professional audiences will not be influenced unduly by celebrities. . . .
You may also be interested in...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Shire Hopes To Sow Future Deals With $50M Venture Fund
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth